A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)
Clinical trial NCT02738970 · COMPLETED
Trial details
- NCT number
- NCT02738970
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-23
- Primary completion
- 2018-05-31
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.